Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

High adherence to a Mediterranean diet could help reduce the risk for obesity-linked cancers by 6%, a new study shows.

Ongoing trials of the next generation of weight loss drugs are revealing something unexpected: Some patients are losing too ...

The GLP-1 weight loss market is a massive one, with some analysts expecting it to be worth around $200 billion by 2031. Hype ...

"Physically, I feel stronger and healthier, but I do regret not focusing on muscle-building sooner," told Sara Conde, 22.

It wasn’t as if she were wasting away, and she rather liked the way she looked at this new weight. Still, she hadn’t been ...

Mindy Kaling knows you're curious about her weight loss. “I know people are really interested in my body and the changes in my body, and I think it’s flattering and sometimes it’s just a little much, ...

Kallyope has slipped out results from a phase 2 trial of its obesity candidates, linking the combination of the two oral ...

Amgen released financial results for the 4th quarter of 2024. Check out why I continue to cover AMGN stock with a 'Buy' ...

CagriSema from Novo Nordisk activates both GLP-1 and amylin receptors. It is currently the subject of several clinical trials ...

We recently published a list of 11 Best Performing Dow Stocks So Far in 2025. In this article, we are going to take a look at ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...